Free Trial
→ Elon Musk’s One Stock Retirement Plan (From Brownstone Research) (Ad)tc pixel Free IPHA Stock Alerts

Innate Pharma (IPHA) Short Interest Ratio & Short Volume

Innate Pharma logo
$1.45 -0.02 (-1.29%)
As of 10:29 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Innate Pharma Short Interest Overview

As of September 30, 2026, Innate Pharma (IPHA) had a short interest of 88,622 shares sold short, representing 0.12% of the public float. This marks a 16.50% increase in short interest since the prior report. The short interest ratio (days to cover) is 1.3, meaning it would take 1.3 days of the average trading volume of 81,418 shares to cover all short positions.

Current Short Interest
88,622 shares
Previous Short Interest
76,073 shares
Change Vs. Previous Month
16.50%
Dollar Volume Sold Short
$144.45 thousand
Short Interest Ratio
1.3 Days to Cover
Last Record Date
September 30, 2026
Outstanding Shares
111,720,000 shares
Short Percent of Float
0.12%
Today's Trading Volume
1,454 shares
Average Trading Volume
81,418 shares
Today's Volume Vs. Average
2%
Short Selling Innate Pharma?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Innate Pharma and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

IPHA Short Interest Over Time

IPHA Days to Cover Over Time

IPHA Percentage of Float Shorted Over Time

Innate Pharma Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/202688,622 shares $144.45 thousand +16.5%0.1%1.25 $1.63
9/15/202676,073 shares $141.50 thousand -7.2%0.1%4.09 $1.86
8/31/202681,961 shares $177.86 thousand -63.9%0.1%1.81 $2.17
8/14/2026227,041 shares $494.95 thousand +49.0%0.4%0.31 $2.18
7/31/2026152,432 shares $266.76 thousand -6.8%0.2%27.54 $1.75
7/15/2026163,552 shares $294.39 thousand -9.1%0.3%22.81 $1.80
6/30/2026179,942 shares $331.09 thousand -14.0%0.3%14.56 $1.84
6/15/2026209,331 shares $374.70 thousand +8.0%0.3%3.45 $1.79
5/29/2026193,882 shares $354.80 thousand -21.1%0.3%5.02 $1.83
5/15/2026245,729 shares $496.37 thousand +171.5%0.4%1.04 $2.02
4/30/202690,515 shares $130.34 thousand +41.0%0.1%3.86 $1.44
4/15/202664,220 shares $108.53 thousand -9.9%0.1%2.28 $1.69
3/31/202671,264 shares $91.22 thousand -6.5%0.1%3.13 $1.28
3/13/202676,183 shares $114.27 thousand -23.2%0.1%4.42 $1.50
2/27/202699,192 shares $170.11 thousand -21.0%0.2%7.28 $1.72
2/13/2026125,617 shares $218.57 thousand -40.3%0.2%6.04 $1.74
1/30/2026210,405 shares $385.04 thousand -7.5%0.3%8.29 $1.83
1/15/2026227,571 shares $400.52 thousand -6.1%0.4%15.18 $1.76
12/31/2025242,455 shares $424.30 thousand +0.6%0.4%6.62 $1.75
12/15/2025241,070 shares $453.21 thousand -0.3%0.4%15.02 $1.88
11/28/2025241,759 shares $473.85 thousand +9.4%0.4%9.51 $1.96
11/14/2025220,987 shares $402.20 thousand +281.7%0.4%0.22 $1.82
10/31/202557,894 shares $114.05 thousand +9.1%0.1%1.82 $1.97
10/15/202553,100 shares $112.04 thousand +9.0%0.1%3.6 $2.11
9/30/202548,700 shares $93.99 thousand +5.0%N/A3.6 $1.93
9/15/202546,400 shares $95.82 thousand -5.3%N/A3.5 $2.07
8/31/202549,000 shares $104.13 thousand -6.0%0.1%4.5 $2.13
8/15/202552,100 shares $111.23 thousand -25.8%N/A5.1 $2.14
7/31/202570,200 shares $148.12 thousand +35.0%0.1%4.8 $2.11
7/15/202552,000 shares $92.04 thousand -14.3%N/A2.9 $1.77
6/30/202560,700 shares $110.17 thousand +17.9%0.1%3.1 $1.82
6/15/202551,500 shares $97.59 thousand -8.4%0.1%2.1 $1.90
5/31/202556,200 shares $121.39 thousand -14.5%0.1%2.4 $2.16
5/15/202565,700 shares $138.63 thousand -82.5%0.1%1.9 $2.11
4/30/2025376,100 shares $838.70 thousand -2.6%N/A1.7 $2.23
4/15/2025386,100 shares $737.45 thousand -5.2%0.7%1.7 $1.91
3/31/2025407,300 shares $724.99 thousand -2.4%0.7%1.8 $1.78
3/15/2025417,100 shares $812.93 thousand -9.6%0.7%1.8 $1.95
2/28/2025461,400 shares $978.17 thousand +199.2%0.8%0.7 $2.12
2/15/2025154,200 shares $299.15 thousand +1.1%0.3%0.2 $1.94
Wall Street legend reveals his top AI stock before Oct. 20 (Ad)

Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock ahead of October 20. His system has spotted at least seven of the top 10 performers every year since 2016, including all ten in the 2022 bear market and every member of the Magnificent Seven before their run higher. Now Chaikin's Power Gauge is turning bullish on an under-the-radar company tied to next-generation AI data centers built under Executive Order 14363, technology he says uses 99 percent less electricity and space while offering far greater computing power.tc pixel

Watch the free interview now to see Chaikin's top AI stock pick
1/31/2025152,500 shares $279.08 thousand +44.7%N/A0.3 $1.83
1/15/2025105,400 shares $179.18 thousand +4.4%N/A0.2 $1.70
12/31/2024101,000 shares $185.84 thousand -88.9%N/A0.2 $1.84
12/15/2024909,800 shares $2.75 million +1,344.1%N/A2 $3.02
11/30/202463,000 shares $97.02 thousand -1.1%N/A0.3 $1.54
11/15/202463,700 shares $91.73 thousand -2.3%N/A6.2 $1.44
10/31/202465,200 shares $123.29 thousand +10.9%N/A7.8 $1.89
10/15/202458,800 shares $119.36 thousand -18.1%N/A7.4 $2.03
9/30/202471,800 shares $164.42 thousand +20.3%N/A10 $2.29
9/15/202459,700 shares $134.92 thousand -8.3%N/A9 $2.26
8/31/202465,100 shares $149.40 thousand -2.5%N/A9.3 $2.30
8/15/202466,800 shares $150.30 thousand +3.6%N/A8.1 $2.25
7/31/202464,500 shares $138.35 thousand -11.5%N/A7.8 $2.15
7/15/202472,900 shares $154.55 thousand +5.2%N/A9.1 $2.12
6/30/202469,300 shares $134.44 thousand -4.9%N/A7.7 $1.94
6/15/202472,900 shares $171.32 thousand +4.1%N/A7 $2.35
5/31/202470,000 shares $191.80 thousand -0.3%N/A6.7 $2.74
5/15/202470,200 shares $175.94 thousand -11.3%N/A7.2 $2.51
4/30/202479,100 shares $182.72 thousand -2.7%N/A8.8 $2.31
4/15/202481,300 shares $196.75 thousand +5.7%N/A7.8 $2.42
3/31/202476,900 shares $221.47 thousand -13.7%N/A7.7 $2.88
3/15/202489,100 shares $217.40 thousand +13.7%N/A7.6 $2.44
2/29/202478,400 shares $205.41 thousand -4.9%N/A4.1 $2.62
2/15/202482,400 shares $212.59 thousand +8.4%N/A4.7 $2.58
1/31/202476,000 shares $203.68 thousand -0.9%N/A4 $2.68
1/15/202476,700 shares $214.76 thousand -8.9%N/A3.7 $2.80
12/31/202384,200 shares $235.76 thousand +55.9%N/A3.9 $2.80
12/15/202354,000 shares $130.14 thousand -5.9%N/A2.6 $2.41
11/30/202357,400 shares $137.76 thousand -4.3%N/A4.3 $2.40
11/15/202360,000 shares $147.60 thousand -6.0%N/A4.2 $2.46
10/31/202363,800 shares $151.84 thousand +11.5%N/A4.4 $2.38
10/15/202357,200 shares $132.42 thousand -8.5%N/A5 $2.32
9/30/202362,500 shares $158.13 thousand -3.4%N/A6 $2.53
9/15/202364,700 shares $192.16 thousand -1.5%N/A6.7 $2.97
8/31/202365,700 shares $191.32 thousand -8.1%N/A5.2 $2.91
8/15/202371,500 shares $206.64 thousand -3.8%N/A6.1 $2.89
7/31/202374,300 shares $218.44 thousand -1.9%N/A6.8 $2.94
7/15/202375,700 shares $244.51 thousand -3.8%N/A6.4 $3.23
6/30/202378,700 shares $242.00 thousand +20.0%N/A6.1 $3.08
6/15/202365,600 shares $213.86 thousand +9.7%N/A4 $3.26
5/31/202359,800 shares $175.81 thousand -4.3%N/A3.8 $2.94
5/15/202362,500 shares $186.88 thousand No ChangeN/A3.6 $2.99
10/31/2022147,600 shares $317.34 thousand +12.8%N/A12.9 $2.15
10/15/2022130,900 shares $261.80 thousand +15.5%N/A12.5 $2.00
9/30/2022113,300 shares $226.60 thousand +1.3%N/A12.7 $2.00
9/15/2022111,900 shares $284.23 thousand +2.3%N/A13.3 $2.54
8/31/2022109,400 shares $293.19 thousand +0.2%N/A6.4 $2.68
8/15/2022109,200 shares $321.05 thousand -10.1%N/A5.9 $2.94
7/31/2022121,500 shares $388.79 thousand -3.6%N/A6.1 $3.20
7/15/2022126,000 shares $347.76 thousand +0.3%N/A4.9 $2.76
Federal Reserve Reveals Disturbing New Plan To Control Your Money (Ad)

Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.tc pixel

Watch the video to learn how this plan could affect you
6/30/2022125,600 shares $339.12 thousand +3.9%N/A4.8 $2.70
6/15/2022120,900 shares $305.88 thousand +1.9%N/A4.6 $2.53
5/31/2022118,700 shares $315.74 thousand -13.6%N/A6.2 $2.66
5/15/2022137,300 shares $394.05 thousand +8.0%N/A6.7 $2.87
4/30/2022127,100 shares $364.78 thousand -9.3%N/A5.7 $2.87
4/15/2022140,100 shares $438.51 thousand +4.0%N/A6 $3.13
3/31/2022134,700 shares $452.59 thousand +105.0%N/A5.3 $3.36
3/15/202265,700 shares $207.61 thousand +13.9%N/A1.6 $3.16
2/28/202257,700 shares $196.76 thousand -2.5%N/A1 $3.41
2/15/202259,200 shares $219.63 thousand -15.6%N/A0.9 $3.71
1/31/202270,100 shares $265.68 thousand -15.3%N/A1 $3.79
1/15/202282,800 shares $375.08 thousand -22.3%N/A1.1 $4.53
12/31/2021106,600 shares $486.10 thousand +247.2%N/A1.3 $4.56
12/15/202130,700 shares $158.11 thousand +0.3%N/A0.3 $5.15
11/30/202130,600 shares $151.78 thousand -39.8%N/A0 $4.96
11/15/202150,800 shares $263.65 thousand +195.4%N/A0 $5.19
10/29/202117,200 shares $99.76 thousand +18.6%N/A0 $5.80
10/15/202114,500 shares $85.12 thousand -89.5%N/A0 $5.87

IPHA Short Interest - Frequently Asked Questions

Short interest is the volume of Innate Pharma shares that have been sold short but have not yet been covered or closed out. As of September 30th, investors have sold 88,622 shares of IPHA short. 0.12% of Innate Pharma's shares are currently sold short. Learn More on Innate Pharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPHA shares currently have a short interest ratio of 1.3. Learn More on Innate Pharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.12% of Innate Pharma's floating shares are currently sold short.

Innate Pharma saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 88,622 shares, an increase of 16.5% from the previous total of 76,073 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.12% of Innate Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Innate Pharma: Sensei Biotherapeutics, Inc. (8.60%), Nuvectis Pharma, Inc. (10.81%), Pharming Group N.V. Sponsored ADR (0.03%), MiMedx Group, Inc (6.59%), DBV Technologies S.A. (1.81%), Shattuck Labs, Inc. (11.96%), Aura Biosciences, Inc. (10.19%), Sinovac Biotech, Ltd. (0.09%), Climb Bio, Inc. (17.37%), Silence Therapeutics PLC Sponsored ADR (4.35%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.10 billion), Invesco QQQ ($52.12 billion), iShares Russell 2000 ETF ($25.28 billion), SPDR S&P Biotech ETF ($11.70 billion), Nebius Group N.V. ($10.54 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($9.69 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.22 billion), iShares 20+ Year Treasury Bond ETF ($8.80 billion), Financial Select Sector SPDR Fund ($7.65 billion), and Lumentum Holdings Inc. ($7.23 billion). View all of the most shorted stocks.

Short selling IPHA is an investing strategy that aims to generate trading profit from Innate Pharma as its price is falling. IPHA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Innate Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPHA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPHA, twice per month. The most recent reporting period available is September, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like IPHA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:IPHA is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 10/9/2026. FINRA publishes updated short interest twice a month.
From Our Partners
The AI Infrastructure Play Kevin O'Leary Is Backing
Kevin O'Leary became a strategic investor in a NASDAQ-listed AI infrastructure company, calling it essentially...
The Tomorrow Investor | Sponsoredtc pixel
Elon Musk’s One Stock Retirement Plan
Jeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...
Brownstone Research | Sponsoredtc pixel
Wall Street legend reveals his top AI stock before Oct. 20
Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...
Chaikin Analytics | Sponsoredtc pixel
How one AI fund pays investors every Thursday
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...
Investors Alley | Sponsoredtc pixel
AI Microcap Teams With Gentex on Next-Gen Military Helmets
Morgan Stanley projects the humanoid robotics market could reach $5 trillion by 2050, with more than 1 billion...
Capital Trends | Sponsoredtc pixel
Federal Reserve Reveals Disturbing New Plan To Control Your Money
Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...
Weiss Ratings | Sponsoredtc pixel
Trump's about to unleash his Midterm Weapon
Trump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...
Monument Traders Alliance | Sponsoredtc pixel
The Iran War Isn’t Chaos. It’s Strategy.
Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...
Behind the Markets | Sponsoredtc pixel